prostate cancer

Candel Therapeutics stock up 172% after Phase III prostate cancer success
Clinical Trials Arena
Wed, 12/11/24 - 11:19 am
Candel Therapeutics
clinical trials
prostate cancer
CAN-2409
Lava burnt by blood cancer drug's performance in phase 1, pivots to preclinical backup
Fierce Biotech
Tue, 12/10/24 - 11:32 am
Lava Therapeutics
clinical trials
LAVA-1207
prostate cancer
blood cancer
Janux impresses Wall Street with new prostate cancer drug results
BioPharma Dive
Tue, 12/3/24 - 11:42 pm
Janux Therapeutics
prostate cancer
clinical trials
JANX007
Bayer expands indications for Nubeqa with new drug application
Clinical Trials Arena
Thu, 11/21/24 - 11:39 am
Bayer
Nubeqa
prostate cancer
FDA
Prostate cancer: Three drug trials to watch
Clinical Trials Arena
Tue, 11/19/24 - 11:22 am
prostate cancer
clinical trials
Candel Therapeutics
ProstAtak
JNJ
Akeega
Pfizer
Mevrometostat
MacroGenics pauses work on vobra duo ADC pending mature survival data
Fierce Biotech
Wed, 11/6/24 - 11:39 am
Macrogenics
vobra duo
antibody drug conjugate
prostate cancer
Essa abandons sole clinical-stage drug after falling short against Xtandi in phase 2 trial
Fierce Biotech
Sun, 11/3/24 - 10:17 pm
Essa Pharma
prostate cancer
masofaniten
Xtandi
Astellas
Pfizer
AngioDynamics launches long-term study of NanoKnife for prostate cancer
Clinical Trials Arena
Thu, 10/24/24 - 09:52 am
AngioDynamics
prostate cancer
NanoKnife
clinical trials
medtehc
Pfizer's cancer drug combo improves overall survival in late-stage study
Reuters
Thu, 10/10/24 - 09:59 am
Pfizer
Talzenna
Xtandi
prostate cancer
J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study
Fierce Pharma
Wed, 10/2/24 - 09:50 pm
JNJ
Erleada
prostate cancer
Astellas
Pfizer
Xtandi
Ipsen shelves Cabometyx combo in prostate cancer after Phase III miss
Clinical Trials Arena
Mon, 09/16/24 - 11:07 am
Ipsen
Carbometyx
clinical trials
prostate cancer
ESMO: Bayer hopes to expand Nubeqa's prostate cancer reach with chemo-free regimen
Fierce Pharma
Mon, 09/16/24 - 09:58 am
ESMO
Bayer
Nubeqa
prostate cancer
Blue Earth Therapeutics partners with UCL for prostate cancer therapy trial
Clinical Trials Arena
Wed, 07/24/24 - 11:35 am
Blue Earth Therapeutics
radioligands
prostate cancer
Bayer eyes Nubeqa’s label expansion in prostate cancer following Phase III win
Clinical Trials Arena
Fri, 07/19/24 - 11:55 am
Bayer
clinical trials
Nubeqa
prostate cancer
Trial sets up wider use of Bayer's Nubeqa in prostate cancer
Pharmaphorum
Wed, 07/17/24 - 11:40 am
Bayer
clinical trials
Nubeqa
prostate cancer
mHSPC
Barinthus lays off 25% of staff, sidelines prostate cancer program to stretch out cash
Fierce Biotech
Thu, 06/13/24 - 10:51 am
Barinthus Biotherapeutics
hepatitis B
clinical trials
prostate cancer
layoffs
ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial
BioSpace
Fri, 05/24/24 - 11:20 am
ASCO 2024
JNJ
JNJ-6420
prostate cancer
clinical trials
patient deaths
radiopharmaceuticals
Five Deaths in Prostate Cancer Trial Send MacroGenics’ Stock Plummeting
BioSpace
Fri, 05/10/24 - 11:16 am
Macrogenics
clinical trials
antibody-drug conjugate
vobramitamab duocarmazine
prostate cancer
patient deaths
Johnson & Johnson reports data from Phase II prostate cancer trial
Clinical Trials Arena
Mon, 05/6/24 - 11:28 am
JNJ
clinical trials
Erleada
prostate cancer
European Commission approves Astellas’ drug for expanded prostate cancer Treatment
Outsourcing Pharma
Thu, 04/25/24 - 05:59 pm
Astellas
Xtandi
Europe
prostate cancer

Pages